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Summary: The generation of leukotrienes 84 (LT84) and C4 (LTC4) by leucocytes
stimulated with Ca ionophore A23187 was examined in 16 patients with asthma (8 with
atopic and 8 with nonatopic asthma) and 12 healthy controls. 1. The LT84 generation by
leucocytes was not significantly different between patients with asthma and healthy
controls. The generation of LTC4 was significantly larger in patients with asthma than in
healthy controls. The LTC4 generation was also significantly larger in patients with
attacks (58.4 ± 38.5 ng/5x106 cells) than in those without attacks (23.3 ± 25.9 ng/
5x106 cells)(p<0.05). 2.ln atopic asthma, the LTC4 production was significantly larger in
patients with attacks (84.7 ± 35.4 ng/5x106 cells) compared to the production in those
without attacks (40.4 ± 27.2 ng/5x106 cells)(p<O.02). However, the production of LT84
was not significantly different between attack and attack-free stages. 3. In nonatopic
asthma, the LTC4 production was also significantly higher in patients with attacks (32.2
± 26.3 ng/5x106 cells) than in those without attacks (12.2 ± 3.5 ng/5x106 cells)(p<0.05).
However, the LT84 production was not significantly different between attack and
nonattack stages. 4. The LTC4 production was significantly larger in atopic asthmatics
compared to the production in nonatopic sUbjects both in attack and nonattack stages.
These results suggest that the generation of LTC4 by leucocytes of patients with asthma
is closely related to IgE-mediated reaction and asthma attacks.
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Introduction
Asthma is characterized by airway inflammation.
Antigen challenge produces both early and late asth-
matic response!). The late asthmatic reaction is closely
related to airway inflammation2,3). Inflammatory cells
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such as lymphocytes, neutrophils and eosinophils, and
a number of cytokines including leukotrienes released
from these cells participate in the late asthmatic
reaction. Among inflammatory cells, activated T
lymphocytes and eosinophils play an important role in
induction and persistence ofthe reaction4).
Leukotrienes are potent pro-inflammatory mediators
contributing to pathophysiological changes of the
airways in asthma. Cysteinyl leukotrienes (cysLTs)
display bronchoconstrictory effects5), increase mucus
formation6) and bronchial wall edema7l• The cysLTs
are mainly generated by eosinophils in the late
asthmatic reaction8). The amount of cysLTs produced
is related to the eosinophil activation state9). Leu-
kotriene B4 (LTB4) stimulates neutrophil chemotaxis
and activation of the cells, leading to the release of
mediators, ernzymes, and superoxides10). LTB4 se-
lectively increases the number and percentage of
neutrophils in the human lung"). It has been shown
that neutrophil inflammation enhances bronchial hy-
perreponsivenessI2,13). LTB4 is mainly generated by
neutrophils. Preincubation of human neutrophils with
granulocyte/macrophage-stimulating factor (GM-CSF)
results in a modest increase in LTB4 production in
response to the chemotactic peptideI4).
In the present study, generation of LTC4 and LTB4
by peripheralleucocytes stimulated with Ca ionophore
A 23187 was examined in patients with asthma.
Subjects and Methods
The subjects of this study was 16 patients (12
females and 4 males) with asthma and 12 healthy
subjects (7 females and 5 males, mean age 56.2 years).
The mean age of patients with asthma was 62.8 years
(range 52-74 years) and mean level of serum IgE was
211 IU/ml (range 61-835 IU/ml). Asthma was diag-
nosed according to the criteria of the American
Thoracic Society (ATS) '5l. Among 16 subjects with
asthma, 8 were atopic, as shown by a positive RAST
score for inhalant allergens, and 8 were nonatopic,
whose mean serum IgE level was under 200 IUlml and
RAST score for inhalant allergens was all negative.
The generation ofleukotrienes, LTC4 and LTB4, by
peripheral leukocytes was assessed by a method
previously reported 16). Buffy coat was separated by
adding a quarter volume of 6% dextran and followed
by being left 1 hour at room temperature. After the
number of the cells was adjusted to 5x106/rnl in Tris
ACM, Ca ionophore A23187 (l p. g) was added to
the cell suspension. The mixed solution was incubated
for 15 min at 37 "C, and centrifuged at 3000 rpm for
30 min after the addition of 4 times volume of
pre-chilled ethanol (finally 80% ethanol). Supernatant
was taken into the syringe filter (Toyo Roshi Co,
Japan), and the filtrate was decompressed and dried up
to solid. The solid was dissolved with 250 p. I of
50% ethanol. The HPLC analysis for LTB4 and LTC4
was performed by a method described by Lam, et al 17l.
The results were expressed as ng/5x106 cells.
Pulmonary function test was carried out in all
patients using a Chestac 33 (Chest Co, Japan) linked to
a computer, when they were attack-free.
IgE antibodies against inhalant allergens, house dust
mite, cockroach and Candida albicans, were estimated
by radioallergosorbent test (RAST), and serum level of
total IgE was measured by radioimmunosorbent test
(RIST).
Statistically significant differences of the mean were
estimated using the unpaired Student't test. A p value
of <0.05 was regarded as significant.
Results
The generation of LTB4 by leucocytes stimulated
with Ca ionophore A23187 was higher in patients with
asthma despite the presence and absence of attacks
than in healthy controls. However, there was no
significant difference in LTB4 generation between
patients with asthma and healthy controls. The genera-
tion of LTC4 by leucocytes was significantly larger in
asthma patients with (58.4 ± 38.5 ng/5x106 cells)
(mean ± SD)(p<O.ool) and without attacks (23.3 ±
25.9 ng/5x106 cells) (p<O.05) compared to the genera-
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In atopic asthma, the production of LTB4 by
leucocytes was higher in patients with attacks than in
those without attacks, however, this was not signifi-
cant. The LTC4 production was significantly larger in
asthmatics with attacks (84.7 ± 35.4 ng/5x106 cells)
compared to the production in those without attacks
(40.4 ± 27.2 ng/5x106 cells)(p<0.02)(Fig.2). In
patients with nonatopic asthma, there was no differ-
ence in LTB4 production between attack and attack-
free stages. However, the LTC4 production in no-
natopic asthma was also significantly larger in patients
with attacks (32.2 ± 26.3 ng/5x106 cells) than in
those without attacks (12.2 ± 3.5 ng/5x106 cells)
(p<0.05)(Fig.3).
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Fig.3. Generation of leukotrienes B4 (LTB4) and C4
(LTC4) by leucocytes in patients with non-
atopic asthma.a;p<0.05.
There was significant difference in LTC4 genera-
tion between atopic and nonatopic subjects with
asthma. During attack stages, the LTC4 generation
was significantly larger in atopic asthmatics compared
to the generation in nonatopie subjects (p<O.OOI).
When they were attack-free, the generation of LTC4
was also significantly higher in atopic than in nonatop-
ic asthmatics (p<O.05).
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Fig.!. Generation of leukotrienes B4 (LTB4)(~ )
and C4 (LTC4)(. ) by leucocytes in healthy
subjects and patients with asthma. a;p<O.OOI,
b;p<O.05, c;p<0.05.
tion in healthy subjects (4.4. ± 4.7 ng/5x106 cells).
The LTC4 generation was also significantly larger in
patients with attacks than in those at attack-free stage
(p<0.05), as shown in Fig. I.
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FIg.2. Generation of leukotrienes B4 (LTB4) and C4
(LTC4) by leucocytes in patients with atopic
asthma. a;p<0.02.
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Discussion
Leukotriene B4 and cysLTs, LTC4, LTD4 and
LTE4, play an important role in pathophysiology of
the airways of bronchial asthma. A number of factors
can influence LTB4 production as well as cysLTs.
LTB4 has a chemotactic action for neutrophils as well
as interleukin 8 (lL8), which causes bronchial hyper-
responsiveness and airway neutrophil accumulation I8).
LTC4 production is almostly exclusively due to
eosinophils8,9,19), Eosinophils appear to be important in
asthma pathophysiology. Accumulation of the cells
into the airways often associated with increased
production of LTC420). The amount of LTC4 produc-
tion by eosinophils depends not only on the number of
the cells but also on the degree of activation2l). When
antigen was challenged into the airways, the concen-
tration of LTC4 incresed strongly correlated with the
number of eosinophils migrated into the airways,
suggesting that antigen causes recruitment and activa-
tion of the cells22).
In the present study, the generation of LTB4 and
LTC4 by leukocytes stimulated with Ca ionophore A
23187 was examined in patients with asthma in
relation to asthma type and asthmatic cycle. IT has
been shown that stimulation with ionophore A23187
induced a significantly higher leukotriene C4 genera-
tion from granulocytes of asthmatic children than from
granulocytes of healthy controls9). They also demon-
strated that granulocytes from patients with a history
of severe asthma displayed a higher LTC4 formation
than granulocytes from patients with less severe
disease.
Our results also showed that the LTC4 generation
was significantly larger in patients with asthma than in
healthy controls. Furthermore, the generation of LTC4
by leucocytes was significantly higher in attack stage
than in attack-free stage. The results are consistent
with the data showing enhanced production of LTC4
by activated eosinophils during antigen challenge22),
Regarding asthma type, the generation of LTC4 by
leucocytes was significantly larger in atopic asthma
compared to the generation in nonatopic disease in
both attack and attack-free stages. An important role
of interleukin 5 (IL-5) in IgE-mediated allergic reac-
tions has been shown by several investigators23,24).
Parallel patterns of increase of lL-5 and eosinophils
imply the possibility of a bidirectional interaction
between them25,26). These results mat suggest a pos-
sibility that LTC4 generation is more closely related to
IgE-mediated reaction than to other reaction. How-
ever, LTB4 generation by leucocytes of patients with
asthma was not significantly different between atopic
and nonatopic asthma, and between attack and attack-
free stage.
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気管支幡息における末梢血白血球のロイコトリエ
ン84およびC4産生能
谷崎勝朗,光延文裕,御船尚志,保崎泰弘,
芦田耕三,柘野浩史,岡本 誠,原田誠之,
湯本英一郎,高田真吾,越智浩二1),原田英雄1)
岡山大学医学部附属病院三朝分院,
1)医学部臨床検査医学
気管支職息 16例 (アトピー型瑞息8例,非ア
トピー型鴨息8例)を対象に,Ca ionophore
A23187刺激時の末梢血白血球のロイコトリエン
B4(LTB4)および C4(LTC4)産生能について検
討した｡1.LTli4産生能は,嘱息症例と健康人
の間に有意の差は見られなかった｡LTC4産生能
は,健康人に比べ鴨息症例で有意に高い傾向が見
られた｡また,職息症例では,非発作時 (23.3
±25.9ng/5xlO6cels)に比べ発作時 (58.4± 38.5
ng/5xlO6cels)に有意に高い値を示した (p<0_05)0
アトピー型嘱息では,非発作時 (40.4± 27.2mg/
5xlO6cels) に比べ発作時 (84.7±35.4ng/5xlO6
cels) に有意の高値を示したが (p<0.02),LTB4
産生に関しては両者間に有意の差は見られなかっ
た｡3.非アトピー型瑞息においても同様,非発
作時 (12.2±3.2ng/5xlO6 cels) に比べ発作時
(32.2±26.3ng/5xlO6cels))で有意の高値であっ
たが (P<0.05), LTB4 では有意差は見られな
かった｡4.LTC4産生能は,発作時､非発作時
とも,アトピー型嘱息で非アトピー型嘱息に比べ
有意に高いことが示唆された｡
以上の結果より,喋息症例における白血球の
LTC4産生能は IgE に mediateされる反応と密
接な関連がある可能性が示唆された｡
